Editas (EDIT) - Pangali Forward P/E

Simbol resmi perusahaan Editas Medicine, Inc. (EDIT)

Editas Medicine, Inc. (EDIT) specializes in developing innovative medical drugs through genome modification. The business is currently focused on the internal development of its project portfolio using funds from licensing deals, while merger transactions are excluded. The market valuation visualization on GURU.Markets shows that the Forward P/E is 0.00. Its first-mover status in CRISPR technologies allows the firm to independently determine the rules for transferring rights to its key patents.

Kapitalisasi marang proyeksi bathi: Editas Medicine Inc (EDIT) kanggo 04.07.2022 - 18.11.2026

Rincian metrik lan analitis perusahaan Editas Medicine, Inc. (EDIT)

- rega saiki lan proyeksi nilai saham:
- indikator kapitalisasi pasar:
Analisis kabeh metrik perusahaan:Editas Medicine, Inc.
Produk mawa merek Editas Corp

Editas Medicine, Inc. (EDIT) developments in CRISPR create long-term investment potential through unique patent protection. The company's expected P/E multiple compares current market capitalization with projected net income after taxes. This indicator measures the market's willingness to pay a premium for future cash flows. Analyzing this trend helps identify the risk of overvaluation or undervalued assets. The stability of this ratio confirms the resilience of the business's market value.

Karo sapa Editas Medicine, Inc. saingan

Prakiraan rega marang bathi TEM (Tempus AI, Inc)|Qiagen Group (QGEN) - Pangali forward rega marang bathi|Rega marang bathi mangsa ngarep ionispharma.com IONS|Kapitalisasi marang proyeksi bathi Repligen Corporation (RGEN)|RNA: Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi CRSP (CRISPR Therapeutics Corp)|WGS: Pangali Forward P/E|Rasio prakiraan rega marang bathi Ultragenyx Corp (RARE)|BEAM (Beam Therapeutics Inc) - Pangali Forward P/E|SRPT: Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Twist Bioscience Corp (TWST)|Prakiraan rega marang bathi 10x Genomics Inc TXG|Intellia Therapeutics, Inc. - Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi STOK|BLFS - Rega marang bathi mangsa ngarep|Wave Life Sciences (WVE) - Prakiraan rega marang bathi|MAZE: Pangali Forward P/E|Sionna Therapeutics, Inc. (SION) - Pangali Forward P/E|Rega marang bathi mangsa ngarep Prime Medicine, Inc.|TSHA (Taysha) - Rasio kapitalisasi marang bathi mangsa ngarep|Prakiraan rega marang bathi QURE (uniQure Pharma)|Kapitalisasi marang proyeksi bathi meiragtx.com|Rega marang bathi mangsa ngarep REGENXBIO RGNX|SLDB - Prakiraan rega marang bathi|Ocugen, Inc. - Pangali Forward P/E|PACB (Pacific Biosciences of California) - Rasio rega marang bathi mangsa ngarep|BNTC: Pangali Forward P/E|DSGN - Kapitalisasi marang proyeksi bathi|RCKT (Rocket Pharma) - Pangali Forward P/E|Rega marang bathi mangsa ngarep FDMT|Rega marang bathi mangsa ngarep Lexeo Therapeutics, Inc. (LXEO)|Korro Bio Inc. - Rasio rega marang bathi mangsa ngarep|Rega marang bathi mangsa ngarep silence-therapeutics.com SLN|PRQR: Rasio rega marang bathi mangsa ngarep|CDXS - Rega marang bathi mangsa ngarep|Kapitalisasi marang proyeksi bathi Sangamo Therapeutics, Inc. SGMO|NAUT (nautilus.bio) - Prakiraan rega marang bathi|Rasio prakiraan rega marang bathi Metagenomi, Inc. (MGX)|Prakiraan rega marang bathi DTIL|Rasio rega marang bathi mangsa ngarep GBIO (generationbio.com)|Rega marang bathi mangsa ngarep Boundless Bio, Inc (BOLD)|Pangali Forward P/E Exicure Inc. (XCUR)|Imunon, Inc. - Prakiraan rega marang bathi|PHIO: Rasio rega marang bathi mangsa ngarep|MBIO - Rega marang bathi mangsa ngarep|Rasio rega marang bathi sing dikarepake RNAZ|Bionano Genomics, Inc. (BNGO) - Rega marang bathi mangsa ngarep|Applied DNA Sciences, Inc. (APDN) - Pangali Forward P/E|BLUE (bluebirdbio.com) - Pangali Forward P/E|Rasio rega marang bathi mangsa ngarep IPA (ImmunoPrecise Antibodies)|Pangali Forward P/E OMGA|Prakiraan rega marang bathi Singular Genomics Systems OMIC|Pangali Forward P/E RGLS (regulusrx.com)|Syros Pharmaceuticals Inc. (SYRS) - Rasio prakiraan rega marang bathi|TBIO: Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi TCON (TRACON)|UBX: Pangali Forward P/E